Research Paper Advance Articles

Identification of prognostic long non-coding RNA signature with potential drugs in hepatocellular carcinoma

Division of OS/RFS cohorts into sub-groups by risk score of lncRNA-based classifiers. (A) Distribution of patients the OS whole cohort according to risk score by the classifier. (B) Sub-groups in OS cohorts with different vital status. (C) Expression of lncRNAs from the OS classifier in high- and low-risk groups of the OS cohort. (D) Distribution of patients the RFS whole cohort according to risk score by the classifier. (E) Sub-groups in RFS cohorts with different recurrence status. (F) Expression of lncRNAs from the RFS classifier in high- and low-risk groups of the RFS cohort.

Figure 3. Division of OS/RFS cohorts into sub-groups by risk score of lncRNA-based classifiers. (A) Distribution of patients the OS whole cohort according to risk score by the classifier. (B) Sub-groups in OS cohorts with different vital status. (C) Expression of lncRNAs from the OS classifier in high- and low-risk groups of the OS cohort. (D) Distribution of patients the RFS whole cohort according to risk score by the classifier. (E) Sub-groups in RFS cohorts with different recurrence status. (F) Expression of lncRNAs from the RFS classifier in high- and low-risk groups of the RFS cohort.